DIAGNOS Inc. (DGNOF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.44 Million CAD | -16.45% |
| 2023 | -2.1 Million CAD | -26.76% |
| 2022 | -2.44 Million CAD | 25.86% |
| 2021 | -2.6 Million CAD | 3.01% |
| 2020 | -2.68 Million CAD | -0.06% |
| 2019 | -2.68 Million CAD | -1.11% |
| 2018 | -2.65 Million CAD | -49.05% |
| 2017 | -1.78 Million CAD | 32.54% |
| 2016 | -2.64 Million CAD | -0.62% |
| 2015 | -2.62 Million CAD | -65.71% |
| 2014 | -1.58 Million CAD | 19.44% |
| 2013 | -1.96 Million CAD | -9.96% |
| 2012 | -1.84 Million CAD | 9.96% |
| 2011 | -1.48 Million CAD | -14.12% |
| 2010 | -1.74 Million CAD | 11.58% |
| 2009 | -1.96 Million CAD | -466.49% |
| 2008 | -347.39 Thousand CAD | 51.21% |
| 2007 | -711.98 Thousand CAD | -27.09% |
| 2006 | -560.21 Thousand CAD | 68.43% |
| 2005 | -1.77 Million CAD | -5125.82% |
| 2004 | -33.95 Thousand CAD | 94.62% |
| 2003 | -631.34 Thousand CAD | 78.07% |
| 2002 | -2.87 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -638.08 Thousand CAD | 0.6% |
| 2024 FY | - CAD | -1.14% |
| 2024 Q1 | -644.03 Thousand CAD | -0.72% |
| 2024 Q2 | -441.78 Thousand CAD | 4.22% |
| 2024 Q3 | -641.9 Thousand CAD | -10.72% |
| 2023 Q4 | -672.11 Thousand CAD | -62.35% |
| 2023 Q3 | -413.97 Thousand CAD | 6.29% |
| 2023 Q2 | -441.78 Thousand CAD | 31.4% |
| 2023 Q1 | -644.03 Thousand CAD | 4.18% |
| 2023 FY | - CAD | -26.76% |
| 2022 Q3 | -570 Thousand CAD | -8.94% |
| 2022 FY | - CAD | 25.86% |
| 2022 Q2 | -523.22 Thousand CAD | 23.43% |
| 2022 Q1 | -683.3 Thousand CAD | -14.17% |
| 2022 Q4 | -672.11 Thousand CAD | -17.91% |
| 2021 Q3 | -538.02 Thousand CAD | -67.07% |
| 2021 Q2 | -322.03 Thousand CAD | 31.94% |
| 2021 FY | - CAD | 3.01% |
| 2021 Q1 | -473.13 Thousand CAD | 52.8% |
| 2021 Q4 | -598.51 Thousand CAD | -11.24% |
| 2020 Q4 | -1 Million CAD | -96.33% |
| 2020 FY | - CAD | -0.06% |
| 2020 Q2 | -485.48 Thousand CAD | 20.02% |
| 2020 Q3 | -510.61 Thousand CAD | -5.18% |
| 2020 Q1 | -607.02 Thousand CAD | -17.83% |
| 2019 FY | - CAD | -1.11% |
| 2019 Q3 | -714.97 Thousand CAD | 10.16% |
| 2019 Q1 | -660.41 Thousand CAD | 35.06% |
| 2019 Q2 | -795.79 Thousand CAD | -20.5% |
| 2019 Q4 | -515.15 Thousand CAD | 27.95% |
| 2018 Q2 | -514.31 Thousand CAD | 37.96% |
| 2018 Q4 | -1.01 Million CAD | -244.7% |
| 2018 FY | - CAD | -49.05% |
| 2018 Q3 | -295.01 Thousand CAD | 42.64% |
| 2018 Q1 | -829.05 Thousand CAD | 73.56% |
| 2017 Q4 | -3.13 Million CAD | -1037.08% |
| 2017 Q1 | -535.62 Thousand CAD | 12.33% |
| 2017 Q2 | -724.02 Thousand CAD | -35.17% |
| 2017 FY | - CAD | 32.54% |
| 2017 Q3 | 334.62 Thousand CAD | 146.22% |
| 2016 Q4 | -610.93 Thousand CAD | -13.73% |
| 2016 FY | - CAD | -0.62% |
| 2016 Q3 | -537.19 Thousand CAD | 36.81% |
| 2016 Q2 | -850.11 Thousand CAD | -32.29% |
| 2016 Q1 | -642.59 Thousand CAD | 3.59% |
| 2015 Q2 | -715.59 Thousand CAD | -12.0% |
| 2015 FY | - CAD | -65.71% |
| 2015 Q1 | -638.9 Thousand CAD | -18.9% |
| 2015 Q4 | -666.51 Thousand CAD | -10.45% |
| 2015 Q3 | -603.47 Thousand CAD | 15.67% |
| 2014 Q2 | -68.31 Thousand CAD | 77.32% |
| 2014 FY | - CAD | 19.44% |
| 2014 Q4 | -537.36 Thousand CAD | -22.76% |
| 2014 Q3 | -437.71 Thousand CAD | -540.78% |
| 2014 Q1 | -301.18 Thousand CAD | -8334.28% |
| 2013 FY | - CAD | -9.96% |
| 2013 Q4 | -3571.00 CAD | 99.33% |
| 2013 Q3 | -532.88 Thousand CAD | -11.91% |
| 2013 Q2 | -476.18 Thousand CAD | -75.33% |
| 2013 Q1 | -271.59 Thousand CAD | -72.43% |
| 2012 Q4 | -157.51 Thousand CAD | 65.16% |
| 2012 Q2 | -534.5 Thousand CAD | 23.51% |
| 2012 Q3 | -452.13 Thousand CAD | 15.41% |
| 2012 FY | - CAD | 9.96% |
| 2012 Q1 | -698.82 Thousand CAD | -76.13% |
| 2011 Q4 | -396.76 Thousand CAD | -139.4% |
| 2011 Q3 | -165.73 Thousand CAD | 64.38% |
| 2011 Q2 | -465.27 Thousand CAD | -8.36% |
| 2011 Q1 | -429.37 Thousand CAD | -15.79% |
| 2011 FY | - CAD | -14.12% |
| 2010 Q1 | -462.67 Thousand CAD | 46.86% |
| 2010 FY | - CAD | 11.58% |
| 2010 Q3 | -410.24 Thousand CAD | 17.35% |
| 2010 Q4 | -370.8 Thousand CAD | 9.61% |
| 2010 Q2 | -496.37 Thousand CAD | -7.28% |
| 2009 Q1 | -406.22 Thousand CAD | -66.15% |
| 2009 FY | - CAD | -466.49% |
| 2009 Q4 | -870.73 Thousand CAD | -15.47% |
| 2009 Q3 | -754.04 Thousand CAD | -875.58% |
| 2009 Q2 | 97.22 Thousand CAD | 123.93% |
| 2008 Q2 | 3128.00 CAD | 101.29% |
| 2008 Q1 | -242.63 Thousand CAD | -49.17% |
| 2008 FY | - CAD | 51.21% |
| 2008 Q4 | -244.48 Thousand CAD | -278.98% |
| 2008 Q3 | 136.59 Thousand CAD | 4266.88% |
| 2007 Q1 | -282.54 Thousand CAD | -378.09% |
| 2007 Q2 | -218.43 Thousand CAD | 22.69% |
| 2007 Q3 | -249.16 Thousand CAD | -14.07% |
| 2007 Q4 | -162.65 Thousand CAD | 34.72% |
| 2007 FY | - CAD | -27.09% |
| 2006 Q1 | -74.13 Thousand CAD | 81.44% |
| 2006 Q3 | -292.45 Thousand CAD | -117.41% |
| 2006 Q4 | -59.09 Thousand CAD | 79.79% |
| 2006 Q2 | -134.51 Thousand CAD | -81.45% |
| 2006 FY | - CAD | 68.43% |
| 2005 Q1 | -406.14 Thousand CAD | -1139.66% |
| 2005 Q4 | -399.44 Thousand CAD | 2.6% |
| 2005 Q3 | -410.09 Thousand CAD | 23.76% |
| 2005 Q2 | -537.91 Thousand CAD | -32.45% |
| 2005 FY | - CAD | -5125.82% |
| 2004 Q4 | 39.06 Thousand CAD | 147.28% |
| 2004 FY | - CAD | 94.62% |
| 2004 Q3 | -82.62 Thousand CAD | -167.07% |
| 2004 Q1 | -87.22 Thousand CAD | 48.17% |
| 2004 Q2 | 123.19 Thousand CAD | 241.24% |
| 2003 Q3 | -122.21 Thousand CAD | -283.14% |
| 2003 Q4 | -168.28 Thousand CAD | -37.7% |
| 2003 FY | - CAD | 78.07% |
| 2003 Q2 | -31.89 Thousand CAD | 87.75% |
| 2003 Q1 | -260.31 Thousand CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Achiko AG | -8.32 Million USD | 70.619% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | -2.84 Million USD | 14.058% |
| Cannabis Sativa, Inc. | -1.11 Million USD | -119.482% |
| CompuMed, Inc. | 690.19 Thousand USD | 454.424% |
| CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 101.15% |
| Cogstate Limited | 9.89 Million USD | 124.731% |
| CareView Communications, Inc. | -210.04 Thousand USD | -1064.63% |
| Craneware plc | 54.26 Million USD | 104.508% |
| Caduceus Software Systems Corp. | -12.29 Million USD | 80.1% |
| Certive Solutions Inc. | -704.66 Thousand USD | -247.144% |
| Drug Free Solution, Inc. | -1.39 Million USD | -75.364% |
| DATATRAK International, Inc. | 2.72 Million USD | 189.652% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -3628.397% |
| Healixa Inc. | -6.32 Million USD | 61.296% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 10.16 Million USD | 124.056% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -474.917% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | - USD | Infinity% |
| iCoreConnect Inc. | -11.87 Million USD | 79.408% |
| IQ-AI Limited | -370.35 Thousand USD | -560.505% |
| Cannabiz Mobile, Inc. | -750.00 USD | -326060.133% |
| Mednow Inc. | -28.12 Million USD | 91.302% |
| Galileo Life Sciences, Inc. | -270.72 Thousand USD | -803.581% |
| MediXall Group, Inc. | -6.52 Million USD | 62.502% |
| Mitesco, Inc. | -11.96 Million USD | 79.553% |
| MobileSmith, Inc. | -13.83 Million USD | 82.322% |
| NantHealth, Inc. | -38.53 Million USD | 93.652% |
| Net Medical Xpress Solutions, Inc. | -1.69 Million USD | -44.064% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.08 Million USD | 79.761% |
| Patient Access Solutions, Inc. | -12.09 Million USD | 79.781% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 286.486% |
| PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 3373.386% |
| Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -19977.159% |
| Renalytix Plc | -28.52 Million USD | 91.423% |
| Revium Recovery Inc. | -678 Thousand USD | -260.797% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -369.00 USD | -662827.1% |
| Vaso Corporation | 4.19 Million USD | 158.312% |
| Vynleads, Inc. | -235.72 Thousand USD | -937.731% |